However, the large molecular size of GLP-1 analogues presents significant formulation challenges for transdermal delivery
References to Wegovy, Ozempic, Rybelsus, Mounjaro, or Saxenda, or other GLP-1 brands, are informational only
Proponents claim these patches can suppress appetite, slow gastric emptying, and improve insulin secretioneffects associated with legitimate GLP-1 receptor agonists
This mechanism would bypass the gastrointestinal tract and provide steady-state drug levels over an extended period
People struggling with significant weight or metabolic concerns need more than a patch
Your doctor will start you on a low dose and gradually increase it to minimise discomfort